Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.
Abbott lowers sales forecast on diagnostics decline, US funding cuts Read More »
The insurer attempted to reassure investors that it can operate through looming policy changes that appear set to worsen existing challenges. It was unsuccessful: Elevance’s stock fell 11% following the second quarter results.
Elevance cuts 2025 guidance as profit falls from higher ACA, Medicaid costs Read More »
Los bosques de la Amazonía peruana no logran recuperarse tras la actividad minera del oro. El problema va más allá de los metales tóxicos que contaminan el suelo: la tierra ha perdido su capacidad de retener agua. Uno de los métodos más usados, la miner&iacu …
La causa de que terrenos selváticos hayan perdido su capacidad de retener agua Read More »
Sarepta Therapeutics appears to have right-sized itself after laying off over a third of its staff, announcing a significant pipeline shift and adding a black box warning to its Duchenne muscular dystrophy gene therapy Elevidys.
Sarepta Up 18% After Business Overhaul as Analysts Cautiously Optimistic Read More »
A merger between the two nonprofits would create a regional system spanning 10 contiguous counties in New Jersey, Delaware, Pennsylvania and Maryland.
Nonprofits ChristianaCare, Virtua Health explore merger Read More »
In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer pitched the direct-to-consumer program as a way to allow uninsured, underinsured and self-pay patients to pay less out of pocket.
BMS, Pfizer Join DTC Trend, Offering Eliquis to Patients for 40% Below List Price Read More »
Aparte de los humanos, muy pocos mamíferos reciben cuidados de su padre. Pero cuando ocurre, ello puede beneficiar de manera notable a su progenie. Un estudio reciente sobre monos babuinos, a cargo de un equipo integrado, entre otros, por David J. Jansen y Elizabeth Archie, ambos de …
In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO Vas Narasimhan told reporters that for most medicines, it typically takes three to four years to completely relocate production.
Una investigación muestra por primera vez que la proteína neuroprotectora PKD1 está reducida en las neuronas de pacientes con enfermedad de Huntington. Un equipo de investigadores del Consejo Superior de Investigaciones Científicas (CSIC) y la Universidad Aut&oac …
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the evolving role of local qualified persons for pharmacovigilance with Ana Pedro Jesuíno, global head local QPPV network at IQVIA.
AI Is Taking Over Drug Safety Monitoring–But There’s One Thing It Can’t Replace Read More »
